Related Experiment Video
Updated: Apr 17, 2026
08:52
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
3.6K
DVWA gene polymorphisms and osteoarthritis
Valentina Bravatà1, Luigi Minafra2, Giusi I Forte3
1IBFM CNR-LATO, Cefalù, PA, Italy. valentina.bravata@ibfm.cnr.it.
BMC Research Notes
|February 5, 2015
Summary
Genetic variations in the DVWA gene may influence osteoarthritis (OA) severity. Specific single nucleotide polymorphisms (SNPs) were associated with radiographic joint damage in Sicilian patients, suggesting a role in OA progression.
Area of Science:
- Genetics
- Orthopedics
- Rheumatology
Background:
- Osteoarthritis (OA) is a degenerative joint disease with a significant genetic component.
- Previous research identified the rs11718863 DVWA single nucleotide polymorphism (SNP) associated with more severe radiographic grades in Sicilian OA patients.
- This study investigates five DVWA SNPs (rs11718863, rs7639618, rs7651842, rs7639807, rs17040821) for potential functional changes impacting OA.
Purpose of the Study:
- To explore potential associations between DVWA gene SNPs and clinical/radiographic features of knee osteoarthritis (OA).
- To investigate the role of specific DVWA SNPs in OA progression and severity.
Main Methods:
- Genotyping of five DVWA SNPs in 61 Sicilian knee OA patients and 100 healthy controls.
- Clinical assessment using American Knee Society Scores (AKSS) and radiographic evaluation using Kellgren and Lawrence (KL) grades.
- Linkage Disequilibrium (LD) analysis to assess SNP haplotype segregation and compare Minor Allele Frequencies (MAF) with European populations.
Main Results:
- All investigated DVWA SNPs exhibited higher Minor Allele Frequencies (MAF) in the Sicilian cohort compared to European populations.
- The rs7639618 SNP demonstrated a statistically significant association with KL radiographic grade.
- Linkage Disequilibrium (LD) was observed between rs11718863 and rs7639618, and among rs7651842, rs7639807, and rs17040821.
- Three individuals were homozygous for the MAF alleles of rs7651842, rs7639807, and rs17040821.
Conclusions:
- This preliminary research highlights potential associations between DVWA SNPs and OA clinical and radiographic parameters.
- The findings support a multidisciplinary approach to OA research, integrating clinical, radiological, and genetic data for improved disease grading.
- DVWA SNPs may serve as potential genetic markers for OA progression and severity.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
17.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
17.1K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
72
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
72
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
132
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
132
01:05Single Nucleotide Polymorphisms-SNPs
20.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.3K
01:27Principles of Pharmacogenetics: Types of Genetic Variants
119
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119
01:33Pleiotropy
44.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.4K